An invited Guest Editorial entitled "Give Cas a Chance," by Fyodor Urnov, PhD, Director of Technology & Translation at the Innovative Genomics ...

Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Colossal Biosciences, which intends to create proxy species of the woolly mammoth, dodo, and Tasmanian tiger, claims it has ...

In one of the case reports, a 75-year-old White man with hereditary coagulopathy presented with myasthenic crisis in the setting of acute pulmonary embolism. Chronic symptoms included diplopia, ptosis ...

The three-horse race to treat a devastating form of muscular dystrophy is now down to two. One of the key players, Avidity ...

Chief, John Sterling, reviews Tim Harris's latest book, In Pursuit of Unicorns: A Journey through 50 Years of Biotechnology.

When a child has a debilitating and fatal disease, a desperate parent might try anything, including risky experimental ...

The company uses gene editing and gene silencing to improve desirable traits—delaying the ripening process in bananas, for ...

Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach ...

Multiple sclerosis (MS) is a chronic disease in which the myelin sheath, an insulation that surrounds nerve cells, is slowly destroyed. | Genetics And Genomics ...

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...